- Home
- Companies
- usa new jersey
- develop new diagnostic
Refine by
Develop New Diagnostic Suppliers In Usa New Jersey
6 companies found
based inMonmouth Junction, NEW JERSEY (USA)
DiamiR is a privately held molecular diagnostics company focused on developing minimally invasive tests for detection and monitoring of pathology based on quantitative analysis of organ-enriched microRNA signatures in plasma for screening, patient ...
based inBellevue, WASHINGTON (USA)
We set out to completely redesign the arrhythmia monitor to elevate signal detection, comfort, and ease of use. Using feedback from patients, clinicians and physicians, we addressed the long-standing complaint in cardiac arrhythmia monitoring that ...
based in, MASSACHUSETTS (USA)
Thermo Scientific instruments, equipment, software, services and consumables empower scientists to solve for complex analytical challenges in pharmaceutical, biotechnology, academic, government, environmental and industrial research, as well as the ...
Designed to make next-generation sequencing (NGS) accessible to clinical laboratories with all levels of sequencing expertise, the Ion Torrent Genexus Dx Integrated Sequencer delivers an effortless user experience while enabling regulatory ...
based inCarlsbad, CALIFORNIA (USA)
DCN Dx, based in Carlsbad, California, is a global leader in IVD CDMO and CRO services, including clinical trials and regulatory services, specializing in the development of custom assays, consumables, and instruments for point-of-use applications. ...
based inWarren, NEW JERSEY (USA)
Auspex Diagnostics focuses on developing and providing advanced cancer diagnostics services to medical professionals and patients to help them personalize cancer treatment plans and improve patients’ quality of living. We started developing the ...
based inParsippany, NEW JERSEY (USA)
Interpace Biosciences (IDXG) is a dynamic and growing leader in the life sciences industry, providing complex molecular analysis for the early diagnosis and treatment of cancer and supporting the development of targeted therapeutics. Since our ...
